US20020193725A1 - Injectable glaucoma device - Google Patents
Injectable glaucoma device Download PDFInfo
- Publication number
- US20020193725A1 US20020193725A1 US10/171,354 US17135402A US2002193725A1 US 20020193725 A1 US20020193725 A1 US 20020193725A1 US 17135402 A US17135402 A US 17135402A US 2002193725 A1 US2002193725 A1 US 2002193725A1
- Authority
- US
- United States
- Prior art keywords
- glaucoma
- drainage shaft
- shaft
- eye
- ostium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
Definitions
- the present invention relates generally to the field of glaucoma treatment devices and in particular to a new and useful implantable glaucoma shunt for relieving internal pressure in a patient's eye.
- the new glaucoma shunt has a foldable plate and reservoir which permit the shunt to be injected into a patient's eye using a cannula.
- Implantable glaucoma shunts are known which require more extensive surgery or require the shunt to be sutured into place on the patient's eye.
- Other shunts are simply cylinders which are injected nearly perpendicularly into the patient's eye and held by frictional fit by eye tissue.
- U.S. Pat. No. 5,127,901 teaches an ophthalmic implant for draining aqueous humor from the anterior chamber of the eye having a transcleral conduit having an inlet opening at one end thereof for communicating with the anterior chamber of an eye, and an outlet opening at an opposite end of the conduit for draining fluid from the anterior chamber.
- An elongated arch shaped subconjunctival channel is connected to the conduit and has an inlet opening into the channel for communicating with the outlet opening of the conduit, the channel having an outlet openings for discharging fluid from the conduit, subconjunctivally over the sclera of the eye.
- a one-way flow resisting valve is provided in the conduit for allowing a flow of fluid to pass under resistance and in only one direction from the inlet to the outlet of the conduit, whereby pressure in the anterior chamber is relieved while avoiding excessive outflow of fluid from the anterior chamber.
- U.S. Pat. No. 5,743,868 discloses a cylindrical drainage tube which can be injected through the surface of a patient's cornea.
- the tube is formed from a hollow rigid cylinder surrounding a porous core layer.
- the device is simply pushed into place using a plunger implant mechanism and positioned so that the exterior end is substantially flush with the surface of the cornea.
- the device lacks any wings or means for securing the device underneath the conjunctiva or sclera.
- a plunger device for implanting cylindrical glaucoma drains is taught by U.S. Pat. No. 5,893,837.
- the device is placed at the end of the plunger for insertion through eye tissue.
- the glaucoma devices inserted using the plunger do not have wings or reservoir flaps.
- U.S. Pat. No. 5,752,928 teaches a glaucoma device having a reservoir plate made of a flexible material, such as silicone rubber. The device is implanted through an incision in the eye followed by suturing the incision.
- U.S. Pat. No. 5,178,604 is for a glaucoma implant having a flexible elastomeric plate.
- the plate is curved to conform to the curvature of a person's eye.
- the plate is inserted through an incision into a position beneath the portion of the eye known as Tenon's capsule and over the sclera.
- the plate is sutured to the sclera.
- the plate can be folded to permit a smaller incision in the eye.
- a preferred material for the plate is silicone elastomer.
- the Baerveldt '604 patent does not teach injecting the device into place and no provision is made for securing the device without sutures until after tissue has grown around the device.
- the glaucoma device in U.S. Pat. No. 5,397,300 also has a flexible plate.
- the plate has at least one through hole to permit the growth of scar tissue to assist holding the plate in position following suturing during the implant procedure.
- a laser is taught for use in making the incision for implanting a glaucoma device in U.S. Pat. No. 5,626,558.
- the device has a plate connected to the exterior end of a tube forming the body of the device.
- the plate may be sutured to the sclera to hold the device in place after insertion.
- U.S. Pat. No. 5,370,607 teaches an implant device having a pair of wings extending from a reservoir around the body of a person's eye. The device is inserted through an incision and sutured into place. A tab positioned between the reservoir and the drainage tube in the center of the reservoir between the wings is used to suture the device in place. The wings are used to stabilize the placement of the device underneath the ocular muscles.
- U.S. Pat. No. 4,554,918 shows a glaucoma device having a reservoir with a flat attachment plate having holes therethrough for receiving sutures or permitting tissue ingrowth.
- the plate is preferably made of silicone rubber, polymethyl methacrylate polymer or other similar polymers, among other compositions.
- a pair of flat rectangular fins extending from the sides of the tube are used to secure the device to the sclera beneath a small flap.
- the prior glaucoma shunt devices are either simple tubes or ports injected directly through the eye, rather than implanted below the conjunctiva, or require tissue cutting, extensive tissue manipulation and suturing to successfully implant the device below the conjunctiva.
- a new glaucoma device comprising a foldable aqueous tube shunt implant for injecting below the conjunctiva of a patient's eye via a hollow cannula.
- the device is used to drain aqueous humor from the anterior chamber of a person's eye to help control glaucoma and intraocular pressure.
- the device has an internal ostium with a flared lip at one end of a shaft having a flattened wing extending to the sides.
- a foldable plate and reservoir are provided at the other end of the shaft and connected to an external ostium of the shaft.
- the flattened wing presents a flat surface to the overlying conjunctiva and helps position the device when used.
- the device is preferably made of silicone or acrylic so that the entire implant is foldable and may be rolled up for insertion via the cannula.
- the implant device may be folded and injected into place within a person's eye, the implant can be implanted using a cannula following laser sclerostomy in a minimally invasive procedure and without incisional surgery. Sutures are not needed to hold the implant in place once it has been injected into position. The lip on the inner ostium holds the device in place.
- FIG. 1 is a top plan view of the glaucoma device of the invention
- FIG. 2 is a partial sectional side elevational view of the glaucoma device implanted into a patient's eye
- FIG. 3 is a sectional side elevational view of the glaucoma device inside an implantation cannula
- FIG. 4 is a top plan view of a further embodiment of the glaucoma device of the invention.
- FIG. 1 shows the glaucoma device 10 of the invention having internal ostium 20 with a flared lip 25 at the end of a drainage shaft 30 .
- the flared lip 25 tapers from the internal ostium 20 to the shaft 30 , so that the diameter of the internal ostium 20 is greater than that of the shaft 30 .
- Foldable wings 40 are formed on the sides of the drainage shaft 30 .
- An external ostium 50 is provided at the other end of the shaft 30 on the upper side of the shaft.
- a foldable plate 60 is attached to the end of shaft 30 opposite the internal ostium 20 .
- the plate 60 has openings 70 in the top surface.
- FIG. 2 shows the glaucoma device 10 implanted in a patient's eye 100 .
- the device 10 is positioned underneath the conjunctiva 120 and rests on the patient's sclera 130 .
- the internal ostium 20 is inserted through the inner edge of the cornea 110 adjacent the pupil 150 and sclera 130 .
- the lens 140 of the patient's eye 100 is shown for reference.
- the glaucoma device 10 is positioned with the internal ostium 20 extending inside the eyeball, while the external ostium 50 and plate 60 are outside the eyeball.
- Higher pressure liquid inside the patient's eye 100 can naturally drain through the glaucoma shunt device 10 via the ostiums 20 , 50 and shaft 30 to outside the eye.
- internal eye, or intraocular, pressure is relieved by the presence of the glaucoma shunt device 10 of the invention.
- the foldable wings 40 help to position the device 10 by providing a flat surface for the overlying conjunctiva 120 to rest upon.
- the wings 40 should be oriented facing toward the conjunctiva 120 to maximize their benefit.
- the plate 60 acts as a foreign object inside the patient's eye which causes tissue to grow around the plate 60 over a period of time. The tissue growth assists in holding the device 10 in place over an extended period of time.
- the entire glaucoma device 10 is made of a foldable biocompatible material. Suitable biocompatible materials include poly methylmethacrylate (PMMA), silicone or acrylic.
- PMMA poly methylmethacrylate
- the materials used to make the plate 60 may be rolled up to a cylinder roughly having the same size diameter as the drainage shaft 30 .
- the wings 40 may be folded up around the sides of the drainage shaft 30 .
- the diameter of the drainage shaft 30 is about 350 microns and the device 10 is about 12 mm long.
- the diameter of the internal ostium 20 is preferably about 500 microns.
- the wings 40 are between 1 and 2 mm across when unfolded.
- FIG. 3 displays the glaucoma device 10 rolled up inside a cannula injector 200 having a plunger 210 and insertion opening 220 .
- the reservoir plate 60 is rolled up to fit within the cannula shaft 205 .
- the plunger 210 can be activated using any known method for pushing objects with plungers, such as by a simple mechanical handle of a type commonly found on syringes.
- the cannula shaft 205 can flex perpendicularly to the longitudinal axis, as shown by arrows F, but does not compress along the longitudinal axis. The flexion assists the implantation of the glaucoma device 10 in a patient's eye.
- the cannula injector 200 can be used to implant the glaucoma device 10 after a laser has been used to make an opening in the patient's eye, such as by laser sclerostomy (ab externo or ab interno).
- the device 10 can be inserted through an opening in the eye created by a prior trabeculectomy.
- a much smaller opening can be used to implant the glaucoma device 10 of the invention, compared to a non-folding implant, since the device 10 is inserted using cannula injector 200 .
- the opening has only to be sufficiently large to permit the cannula opening 220 to pass through.
- the cannula injector 200 preferably has a diameter of between 500-700 microns and is made to permit flexibility perpendicular to the longitudinal axis, but not compression of the longitudinal axis.
- the device 10 is inserted and unfolded beneath the conjunctiva 120 of the patient's eye.
- the internal ostium 20 and flared lip 25 are positioned through the side of the eyeball.
- the flared lip 25 and plate 60 hold the device in place in conjunction with the wings 40 , so that no suturing is needed.
- the device 10 Since the laser sclerostomy and implant injection can both be done in a doctor's office, the device 10 provides a new level of convenience and simplicity heretofore unknown in glaucoma treatment. When a prior trabeculectomy opening is used, the procedure is further simplified by the elimination of the need for laser. A patient no longer has to visit the hospital or endure a lengthy procedure to have a glaucoma shunt implanted. The recovery time is much shorter, since even when a laser is used, the laser creates a much smaller opening through the eye of the patient, and no suturing is needed to secure the device 10 in place in the patient's eye 100 .
- the device 10 permits the in-office conversion of previous failed non-implant filtration surgery to successful tube shunt mediated filtration.
- the glaucoma device 10 allows patients whose trabeculectomies have failed to undergo an in-office implantation using the old, failed trabeculectomy site to re-establish the flow of aqueous out of the eye. Thus, additional incisional surgery in a hospital operating room is not required when the device 10 of the invention is used.
- a pigmented stripe 90 is provided longitudinally down one side of the drainage shaft 30 .
- the stripe 90 is colored to be distinguishable from the tissue in which the device 10 is going to be implanted as described above.
- the stripe 90 is colored differently from the eye tissues surrounding where the device 10 will be implanted.
- a laser having an appropriately tuned frequency is used to make one or more fenestrations or holes through the wall of drainage shaft 30 where the stripe 90 is located.
- the pigment of the stripe 90 and the frequency of the laser should be selected so that the laser will pass through the tissues surrounding the implant device 10 and cause the least amount of damage possible.
- the number of holes created in the striped portion 90 of the drainage shaft 30 wall will affect the flow rate of aqueous through the device 10 from the patient's eye.
- the drainage shaft 30 wall thickness in the area of the stripe 90 is reduced from that of the remainder of the drainage shaft 30 .
- the laser can more easily be used to perforate the wall of the drainage shaft 30 where the stripe 90 is provided.
- a ligature suture 95 is provided around an end of the tube adjacent the external ostium 50 .
- the ligature suture 95 is tied around the end in a manner which permits the ligature suture 95 to be tightened once the device 10 has been implanted.
- the ligature suture 95 is used to constrict the flow of aqueous through the device 10 when it is initially placed in the patient's eye. It is well known that the initial depressurization of the eye during this type of glaucoma treatment procedure results in much increased liquid flow than after a period of time has passed.
- a ligature suture 95 is used since it will dissolve after a short period of time, such as 10-20 days, and once the suture 95 is dissolved, normal fluid flow through the device 10 is allowed.
Abstract
A glaucoma device includes an aqueous tube shunt implant with a foldable reservoir plate for injecting below the conjunctiva of a patient's eye via a hollow cannula. The device has an internal ostium with a flared lip at one end of a shaft having a flattened wing extending to the sides. A foldable plate and reservoir are provided at the at the other end of the shaft and connected to an external ostium of the shaft. The flattened wing presents a flat surface to the overlying conjunctiva and helps position the device when used. The device is preferably made of silicone or acrylic so that the entire implant is foldable and may be rolled up for insertion via the cannula. Other improvements and a method for implanting the device are disclosed as well.
Description
- The present invention relates generally to the field of glaucoma treatment devices and in particular to a new and useful implantable glaucoma shunt for relieving internal pressure in a patient's eye. The new glaucoma shunt has a foldable plate and reservoir which permit the shunt to be injected into a patient's eye using a cannula.
- Implantable glaucoma shunts are known which require more extensive surgery or require the shunt to be sutured into place on the patient's eye. Other shunts are simply cylinders which are injected nearly perpendicularly into the patient's eye and held by frictional fit by eye tissue.
- U.S. Pat. No. 5,127,901 teaches an ophthalmic implant for draining aqueous humor from the anterior chamber of the eye having a transcleral conduit having an inlet opening at one end thereof for communicating with the anterior chamber of an eye, and an outlet opening at an opposite end of the conduit for draining fluid from the anterior chamber. An elongated arch shaped subconjunctival channel is connected to the conduit and has an inlet opening into the channel for communicating with the outlet opening of the conduit, the channel having an outlet openings for discharging fluid from the conduit, subconjunctivally over the sclera of the eye. A one-way flow resisting valve is provided in the conduit for allowing a flow of fluid to pass under resistance and in only one direction from the inlet to the outlet of the conduit, whereby pressure in the anterior chamber is relieved while avoiding excessive outflow of fluid from the anterior chamber.
- The shunt of U.S. Pat. No. 5,127,901 is not foldable, however and must still be implanted into a patient's eye using surgical cutting techniques.
- Other glaucoma shunts include U.S. Pat. No. 5,743,868, for example, which discloses a cylindrical drainage tube which can be injected through the surface of a patient's cornea. The tube is formed from a hollow rigid cylinder surrounding a porous core layer. The device is simply pushed into place using a plunger implant mechanism and positioned so that the exterior end is substantially flush with the surface of the cornea. The device lacks any wings or means for securing the device underneath the conjunctiva or sclera.
- A plunger device for implanting cylindrical glaucoma drains is taught by U.S. Pat. No. 5,893,837. The device is placed at the end of the plunger for insertion through eye tissue. The glaucoma devices inserted using the plunger do not have wings or reservoir flaps.
- U.S. Pat. No. 5,752,928 teaches a glaucoma device having a reservoir plate made of a flexible material, such as silicone rubber. The device is implanted through an incision in the eye followed by suturing the incision.
- U.S. Pat. No. 5,178,604 is for a glaucoma implant having a flexible elastomeric plate. The plate is curved to conform to the curvature of a person's eye. The plate is inserted through an incision into a position beneath the portion of the eye known as Tenon's capsule and over the sclera. The plate is sutured to the sclera. The plate can be folded to permit a smaller incision in the eye. A preferred material for the plate is silicone elastomer. The Baerveldt '604 patent does not teach injecting the device into place and no provision is made for securing the device without sutures until after tissue has grown around the device.
- A continuation-in-part patent, U.S. Pat. No. 5,397,300, discloses a similar device. The glaucoma device in U.S. Pat. No. 5,397,300 also has a flexible plate. The plate has at least one through hole to permit the growth of scar tissue to assist holding the plate in position following suturing during the implant procedure.
- A laser is taught for use in making the incision for implanting a glaucoma device in U.S. Pat. No. 5,626,558. The device has a plate connected to the exterior end of a tube forming the body of the device. The plate may be sutured to the sclera to hold the device in place after insertion.
- U.S. Pat. No. 5,370,607 teaches an implant device having a pair of wings extending from a reservoir around the body of a person's eye. The device is inserted through an incision and sutured into place. A tab positioned between the reservoir and the drainage tube in the center of the reservoir between the wings is used to suture the device in place. The wings are used to stabilize the placement of the device underneath the ocular muscles.
- U.S. Pat. No. 4,554,918 shows a glaucoma device having a reservoir with a flat attachment plate having holes therethrough for receiving sutures or permitting tissue ingrowth. The plate is preferably made of silicone rubber, polymethyl methacrylate polymer or other similar polymers, among other compositions. A pair of flat rectangular fins extending from the sides of the tube are used to secure the device to the sclera beneath a small flap.
- The prior glaucoma shunt devices are either simple tubes or ports injected directly through the eye, rather than implanted below the conjunctiva, or require tissue cutting, extensive tissue manipulation and suturing to successfully implant the device below the conjunctiva.
- It is an object of the present invention to provide a glaucoma shunt which can be implanted in a patient's eye using minimally invasive surgery techniques.
- It is a further object of the invention to provide an implantable glaucoma device which does not require sutures to hold the device in position once the device has been implanted in a patient's eye.
- Accordingly, a new glaucoma device is provided comprising a foldable aqueous tube shunt implant for injecting below the conjunctiva of a patient's eye via a hollow cannula. The device is used to drain aqueous humor from the anterior chamber of a person's eye to help control glaucoma and intraocular pressure.
- The device has an internal ostium with a flared lip at one end of a shaft having a flattened wing extending to the sides. A foldable plate and reservoir are provided at the other end of the shaft and connected to an external ostium of the shaft. The flattened wing presents a flat surface to the overlying conjunctiva and helps position the device when used.
- The device is preferably made of silicone or acrylic so that the entire implant is foldable and may be rolled up for insertion via the cannula.
- Since the entire implant device may be folded and injected into place within a person's eye, the implant can be implanted using a cannula following laser sclerostomy in a minimally invasive procedure and without incisional surgery. Sutures are not needed to hold the implant in place once it has been injected into position. The lip on the inner ostium holds the device in place.
- The various features of novelty which characterize the invention are pointed out with particularity in the claims annexed to and forming a part of this disclosure. For a better understanding of the invention, its operating advantages and specific objects attained by its uses, reference is made to the accompanying drawings and descriptive matter in which a preferred embodiment of the invention is illustrated.
- In the drawings:
- FIG. 1 is a top plan view of the glaucoma device of the invention;
- FIG. 2 is a partial sectional side elevational view of the glaucoma device implanted into a patient's eye;
- FIG. 3 is a sectional side elevational view of the glaucoma device inside an implantation cannula; and
- FIG. 4 is a top plan view of a further embodiment of the glaucoma device of the invention.
- Referring now to the drawings, in which like reference numerals are used to refer to the same or similar elements, FIG. 1 shows the
glaucoma device 10 of the invention havinginternal ostium 20 with a flaredlip 25 at the end of adrainage shaft 30. The flaredlip 25 tapers from theinternal ostium 20 to theshaft 30, so that the diameter of theinternal ostium 20 is greater than that of theshaft 30. -
Foldable wings 40 are formed on the sides of thedrainage shaft 30. Anexternal ostium 50 is provided at the other end of theshaft 30 on the upper side of the shaft. Afoldable plate 60 is attached to the end ofshaft 30 opposite theinternal ostium 20. Theplate 60 hasopenings 70 in the top surface. - FIG. 2 shows the
glaucoma device 10 implanted in a patient'seye 100. Thedevice 10 is positioned underneath theconjunctiva 120 and rests on the patient'ssclera 130. Theinternal ostium 20 is inserted through the inner edge of thecornea 110 adjacent thepupil 150 andsclera 130. The lens 140 of the patient'seye 100 is shown for reference. - As seen in the drawing, the
glaucoma device 10 is positioned with theinternal ostium 20 extending inside the eyeball, while theexternal ostium 50 andplate 60 are outside the eyeball. Higher pressure liquid inside the patient'seye 100 can naturally drain through theglaucoma shunt device 10 via theostiums shaft 30 to outside the eye. Thus, internal eye, or intraocular, pressure is relieved by the presence of theglaucoma shunt device 10 of the invention. - The
foldable wings 40 help to position thedevice 10 by providing a flat surface for theoverlying conjunctiva 120 to rest upon. Thewings 40 should be oriented facing toward theconjunctiva 120 to maximize their benefit. Theplate 60 acts as a foreign object inside the patient's eye which causes tissue to grow around theplate 60 over a period of time. The tissue growth assists in holding thedevice 10 in place over an extended period of time. - The
entire glaucoma device 10 is made of a foldable biocompatible material. Suitable biocompatible materials include poly methylmethacrylate (PMMA), silicone or acrylic. The materials used to make theplate 60 may be rolled up to a cylinder roughly having the same size diameter as thedrainage shaft 30. Similarly, thewings 40 may be folded up around the sides of thedrainage shaft 30. - Preferably, the diameter of the
drainage shaft 30 is about 350 microns and thedevice 10 is about 12 mm long. The diameter of theinternal ostium 20 is preferably about 500 microns. Thewings 40 are between 1 and 2 mm across when unfolded. - FIG. 3 displays the
glaucoma device 10 rolled up inside acannula injector 200 having aplunger 210 andinsertion opening 220. Thereservoir plate 60 is rolled up to fit within thecannula shaft 205. Theplunger 210 can be activated using any known method for pushing objects with plungers, such as by a simple mechanical handle of a type commonly found on syringes. In a preferred embodiment of thecannula injector 200, thecannula shaft 205 can flex perpendicularly to the longitudinal axis, as shown by arrows F, but does not compress along the longitudinal axis. The flexion assists the implantation of theglaucoma device 10 in a patient's eye. - The
cannula injector 200 can be used to implant theglaucoma device 10 after a laser has been used to make an opening in the patient's eye, such as by laser sclerostomy (ab externo or ab interno). Alternatively, thedevice 10 can be inserted through an opening in the eye created by a prior trabeculectomy. - A much smaller opening can be used to implant the
glaucoma device 10 of the invention, compared to a non-folding implant, since thedevice 10 is inserted usingcannula injector 200. The opening has only to be sufficiently large to permit thecannula opening 220 to pass through. Thecannula injector 200 preferably has a diameter of between 500-700 microns and is made to permit flexibility perpendicular to the longitudinal axis, but not compression of the longitudinal axis. Thedevice 10 is inserted and unfolded beneath theconjunctiva 120 of the patient's eye. Theinternal ostium 20 and flaredlip 25 are positioned through the side of the eyeball. The flaredlip 25 andplate 60 hold the device in place in conjunction with thewings 40, so that no suturing is needed. - Since the laser sclerostomy and implant injection can both be done in a doctor's office, the
device 10 provides a new level of convenience and simplicity heretofore unknown in glaucoma treatment. When a prior trabeculectomy opening is used, the procedure is further simplified by the elimination of the need for laser. A patient no longer has to visit the hospital or endure a lengthy procedure to have a glaucoma shunt implanted. The recovery time is much shorter, since even when a laser is used, the laser creates a much smaller opening through the eye of the patient, and no suturing is needed to secure thedevice 10 in place in the patient'seye 100. - The
device 10 permits the in-office conversion of previous failed non-implant filtration surgery to successful tube shunt mediated filtration. Theglaucoma device 10 allows patients whose trabeculectomies have failed to undergo an in-office implantation using the old, failed trabeculectomy site to re-establish the flow of aqueous out of the eye. Thus, additional incisional surgery in a hospital operating room is not required when thedevice 10 of the invention is used. - In a further embodiment of the
glaucoma device 10 shown in FIG. 4, apigmented stripe 90 is provided longitudinally down one side of thedrainage shaft 30. Thestripe 90 is colored to be distinguishable from the tissue in which thedevice 10 is going to be implanted as described above. Preferably, thestripe 90 is colored differently from the eye tissues surrounding where thedevice 10 will be implanted. - Once the
device 10 has been implanted, a laser having an appropriately tuned frequency is used to make one or more fenestrations or holes through the wall ofdrainage shaft 30 where thestripe 90 is located. The pigment of thestripe 90 and the frequency of the laser should be selected so that the laser will pass through the tissues surrounding theimplant device 10 and cause the least amount of damage possible. The number of holes created in thestriped portion 90 of thedrainage shaft 30 wall will affect the flow rate of aqueous through thedevice 10 from the patient's eye. - In a preferred version of the
device 10 having the pigmentedstripe 90, thedrainage shaft 30 wall thickness in the area of thestripe 90 is reduced from that of the remainder of thedrainage shaft 30. The laser can more easily be used to perforate the wall of thedrainage shaft 30 where thestripe 90 is provided. - In yet another embodiment of the
device 10, aligature suture 95 is provided around an end of the tube adjacent theexternal ostium 50. The ligature suture 95 is tied around the end in a manner which permits the ligature suture 95 to be tightened once thedevice 10 has been implanted. The ligature suture 95 is used to constrict the flow of aqueous through thedevice 10 when it is initially placed in the patient's eye. It is well known that the initial depressurization of the eye during this type of glaucoma treatment procedure results in much increased liquid flow than after a period of time has passed. By initially constricting the flow of aqueous through thedevice 10 using theligature suture 95, the patient's eye is prevented from being excessively depressurized. Aligature suture 95 is used since it will dissolve after a short period of time, such as 10-20 days, and once thesuture 95 is dissolved, normal fluid flow through thedevice 10 is allowed. - While a specific embodiment of the invention has been shown and described in detail to illustrate the application of the principles of the invention, it will be understood that the invention may be embodied otherwise without departing from such principles.
Claims (21)
1. A glaucoma device for implanting in the eye of a patient to relieve intraocular pressure, the device comprising:
a drainage shaft;
an internal ostium at one end of the drainage shaft, the internal ostium having a flared lip;
an external ostium adjacent the second end of the drainage shaft on an upper side of the shaft;
a foldable plate connected to the second end of the drainage shaft; and
a pair of foldable wings extending from each of the left and right sides of the drainage shaft.
2. A glaucoma device according to claim 1 , wherein the foldable wings and foldable reservoir plate are made of a biocompatible material.
3. A glaucoma device according to claim 2 , wherein the biocompatible material is one of PMMA, a silicone and an acrylic.
4. A glaucoma device according to claim 1 , wherein the drainage shaft has a diameter of about 350 microns and the internal ostium has a diameter of about 500 microns.
5. A glaucoma device according to claim 1 , further comprising a longitudinal pigmented stripe on the drainage shaft.
6. A glaucoma device according to claim 5 , wherein the pigmented stripe is colored differently from tissues found in a human eye.
7. A glaucoma device according to claim 5 , wherein the drainage shaft wall has a reduced thickness where the pigmented stripe is located relative to the remainder of the drainage shaft wall.
8. A glaucoma device according to claim 1 , further comprising a ligature suture constrictably tied around the end of the drainage shaft adjacent the external ostium.
9. A glaucoma device according to claim 2 , wherein the plate and wings are rolled to have a diameter which is about the same as a shaft diameter of the drainage shaft.
10. A glaucoma shunt implantation kit comprising:
a glaucoma shunt having a drainage shaft, an internal ostium at one end of the drainage shaft, the internal ostium having a flared lip, an external ostium adjacent the second end of the drainage shaft on an upper side of the shaft, a foldable plate connected to the second end of the drainage shaft, a pair of foldable wings extending from each of the left and right sides of the drainage shaft; and
a hollow cannula injector having means for pushing the glaucoma shunt through the injector after the glaucoma shunt has been inserted within the injector with the plate and wings folded to a diameter less than an inner diameter of the injector.
11. A kit according to claim 10 , wherein the cannula injector can flex perpendicular to its longitudinal axis to facilitate implantation of the glaucoma shunt.
12. A kit according to claim 10 , wherein the glaucoma shunt is made of a biocompatible material.
13. A kit according to claim 12 , wherein the biocompantible material is selected from the group consisting of PMMA, acrylic and silicone.
14. A kit according to claim 10 , wherein the inner diameter of the injector is between 500 and 700 microns.
15. A method of implanting a glaucoma shunt in a patient's eye, comprising:
providing a glaucoma shunt having a drainage shaft, an internal ostium at one end of the drainage shaft, the internal ostium having a flared lip, an external ostium adjacent the second end of the drainage shaft on an upper side of the shaft, a foldable plate connected to the second end of the drainage shaft, a pair of foldable wings extending from each of the left and right sides of the drainage shaft;
folding the glaucoma shunt to fit within a hollow cannula injector;
providing an implant opening in the patient's eye;
inserting the cannula injector with the glaucoma shunt through the implant opening;
injecting the glaucoma shunt below a conjunctiva of the patient's eye;
positioning the glaucoma shunt with the internal ostium inside the patient's eye and the wings and plate unfolded;
removing the cannula injector; and
closing the implant opening.
16. A method according to claim 15 , wherein providing the implant opening comprises performing a laser sclerostomy on a patient's eye to create the implant opening.
17. A method according to claim 16 , wherein the glaucoma shunt further comprises a longitudinal pigmented stripe on the drainage shaft, the method further comprising using a laser, after injecting and positioning the glaucoma shunt, to make fenestrations in the drainage shaft where the pigmented stripe is located.
18. A method according to claim 16 , further comprising tightening a ligature suture around the drainage shaft to to constrict the initial flow of aqueous through the glaucoma shunt.
19. A method according to claim 15 , wherein providing the implant opening comprises using the site of a previous trabeculectomy as the implant opening.
20. A method according to claim 19 , wherein the glaucoma shunt further comprises a longitudinal pigmented stripe on the drainage shaft, the method further comprising using a laser, after injecting and positioning the glaucoma shunt, to make fenestrations in the drainage shaft where the pigmented stripe is located.
21. A method according to claim 16 , further comprising tightening a ligature suture around the drainage shaft to to constrict the initial flow of aqueous through the glaucoma shunt.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/171,354 US20020193725A1 (en) | 2000-02-24 | 2002-06-13 | Injectable glaucoma device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/511,979 US6471666B1 (en) | 2000-02-24 | 2000-02-24 | Injectable glaucoma device |
US10/171,354 US20020193725A1 (en) | 2000-02-24 | 2002-06-13 | Injectable glaucoma device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/511,979 Continuation US6471666B1 (en) | 2000-02-24 | 2000-02-24 | Injectable glaucoma device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020193725A1 true US20020193725A1 (en) | 2002-12-19 |
Family
ID=24037195
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/511,979 Expired - Lifetime US6471666B1 (en) | 2000-02-24 | 2000-02-24 | Injectable glaucoma device |
US10/171,354 Abandoned US20020193725A1 (en) | 2000-02-24 | 2002-06-13 | Injectable glaucoma device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/511,979 Expired - Lifetime US6471666B1 (en) | 2000-02-24 | 2000-02-24 | Injectable glaucoma device |
Country Status (1)
Country | Link |
---|---|
US (2) | US6471666B1 (en) |
Cited By (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050267398A1 (en) * | 2004-05-27 | 2005-12-01 | Dimitri Protopsaltis | Glaucoma shunt |
WO2007084582A2 (en) | 2006-01-17 | 2007-07-26 | Forsight Labs, Llc | Drug delivery treatment device |
US7291125B2 (en) | 2003-11-14 | 2007-11-06 | Transcend Medical, Inc. | Ocular pressure regulation |
US20090043321A1 (en) * | 2004-04-29 | 2009-02-12 | Iscience Interventional Corporation | Apparatus And Method For Surgical Enhancement Of Aqueous Humor Drainage |
US20090177138A1 (en) * | 2007-11-07 | 2009-07-09 | Brown Reay H | Shunt Device for Glaucoma Treatment |
US8167939B2 (en) | 2009-01-28 | 2012-05-01 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US20120281208A1 (en) * | 2009-07-21 | 2012-11-08 | National University Corp. Okayama University | Chamber for optical observation, method for optically observing sample, and method for manufacturing lower transparent plate |
EP2526910A1 (en) | 2006-01-17 | 2012-11-28 | Transcend Medical, Inc. | Glaucoma treatment device |
US8444588B2 (en) | 2003-05-05 | 2013-05-21 | Transcend Medical, Inc. | Internal shunt and method for treating glaucoma |
US8529492B2 (en) | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
WO2013155252A1 (en) * | 2012-04-11 | 2013-10-17 | Baylor College Of Medicine | Ophthalmic implant |
US20130317411A1 (en) * | 2012-05-23 | 2013-11-28 | Ghansham Das AGARWAL | Device for Treatment of Glaucoma |
US8617139B2 (en) | 2008-06-25 | 2013-12-31 | Transcend Medical, Inc. | Ocular implant with shape change capabilities |
US8672870B2 (en) | 2007-07-17 | 2014-03-18 | Transcend Medical, Inc. | Ocular implant with hydrogel expansion capabilities |
US8758290B2 (en) | 2010-11-15 | 2014-06-24 | Aquesys, Inc. | Devices and methods for implanting a shunt in the suprachoroidal space |
RU2524197C2 (en) * | 2012-10-24 | 2014-07-27 | Закрытое акционерное общество "Екатеринбургский центр МНТК "Микрохирургия глаза" | Method for surgical treatment of closed-angle glaucoma with organic block of angle of anterior chamber with preserving native crystalline lens |
US8852137B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for implanting a soft gel shunt in the suprachoroidal space |
US9155656B2 (en) | 2012-04-24 | 2015-10-13 | Transcend Medical, Inc. | Delivery system for ocular implant |
US9414962B2 (en) | 2012-04-23 | 2016-08-16 | Das Agarwal Ghansham | Device for treatment of glaucoma and prevention of sub-scleral fibrosis and blockage |
US9480598B2 (en) | 2012-09-17 | 2016-11-01 | Novartis Ag | Expanding ocular implant devices and methods |
US9492320B2 (en) | 1999-04-26 | 2016-11-15 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US9572963B2 (en) | 2001-04-07 | 2017-02-21 | Glaukos Corporation | Ocular disorder treatment methods and systems |
US9763829B2 (en) | 2012-11-14 | 2017-09-19 | Novartis Ag | Flow promoting ocular implant |
US9883969B2 (en) | 2011-12-08 | 2018-02-06 | Aquesys, Inc. | Intrascleral shunt placement |
US9980854B2 (en) | 2010-11-15 | 2018-05-29 | Aquesys, Inc. | Shunt placement through the sclera |
US9987163B2 (en) | 2013-04-16 | 2018-06-05 | Novartis Ag | Device for dispensing intraocular substances |
US9993368B2 (en) | 2000-04-14 | 2018-06-12 | Glaukos Corporation | System and method for treating an ocular disorder |
US10004638B2 (en) | 2010-11-15 | 2018-06-26 | Aquesys, Inc. | Intraocular shunt delivery |
US10080682B2 (en) | 2011-12-08 | 2018-09-25 | Aquesys, Inc. | Intrascleral shunt placement |
US10085633B2 (en) | 2012-04-19 | 2018-10-02 | Novartis Ag | Direct visualization system for glaucoma treatment |
US10195078B2 (en) | 2013-02-19 | 2019-02-05 | Aquesys, Inc. | Adjustable intraocular flow regulation |
US10271989B2 (en) | 2012-03-26 | 2019-04-30 | Glaukos Corporation | System and method for delivering multiple ocular implants |
US10285856B2 (en) | 2001-08-28 | 2019-05-14 | Glaukos Corporation | Implant delivery system and methods thereof for treating ocular disorders |
US10307293B2 (en) | 2010-11-15 | 2019-06-04 | Aquesys, Inc. | Methods for intraocular shunt placement |
US10307292B2 (en) | 2011-07-18 | 2019-06-04 | Mor Research Applications Ltd | Device for adjusting the intraocular pressure |
US10369048B2 (en) | 2013-06-28 | 2019-08-06 | Aquesys, Inc. | Intraocular shunt implantation |
US10406029B2 (en) | 2001-04-07 | 2019-09-10 | Glaukos Corporation | Ocular system with anchoring implant and therapeutic agent |
US10463537B2 (en) | 2015-06-03 | 2019-11-05 | Aquesys Inc. | Ab externo intraocular shunt placement |
US10485701B2 (en) | 2002-04-08 | 2019-11-26 | Glaukos Corporation | Devices and methods for glaucoma treatment |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US10524959B2 (en) | 2013-02-27 | 2020-01-07 | Aquesys, Inc. | Intraocular shunt implantation methods and devices |
US10842671B2 (en) | 2010-11-15 | 2020-11-24 | Aquesys, Inc. | Intraocular shunt placement in the suprachoroidal space |
US10959941B2 (en) | 2014-05-29 | 2021-03-30 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
US11058581B2 (en) | 2017-07-20 | 2021-07-13 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
US11166849B2 (en) | 2017-07-20 | 2021-11-09 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
US11246753B2 (en) | 2017-11-08 | 2022-02-15 | Aquesys, Inc. | Manually adjustable intraocular flow regulation |
US11291585B2 (en) | 2020-02-14 | 2022-04-05 | Shifamed Holdings, Llc | Shunting systems with rotation-based flow control assemblies, and associated systems and methods |
WO2022149249A1 (en) * | 2021-01-07 | 2022-07-14 | 株式会社ドックスネット | Implant and implant system |
US11517477B2 (en) | 2019-10-10 | 2022-12-06 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
US11529258B2 (en) | 2020-01-23 | 2022-12-20 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
US11596550B2 (en) | 2020-04-16 | 2023-03-07 | Shifamed Holdings, Llc | Adjustable glaucoma treatment devices and associated systems and methods |
US11737920B2 (en) | 2020-02-18 | 2023-08-29 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts having non-linearly arranged flow control elements, and associated systems and methods |
US11766355B2 (en) | 2020-03-19 | 2023-09-26 | Shifamed Holdings, Llc | Intraocular shunts with low-profile actuation elements and associated systems and methods |
US11865283B2 (en) | 2021-01-22 | 2024-01-09 | Shifamed Holdings, Llc | Adjustable shunting systems with plate assemblies, and associated systems and methods |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8313454B2 (en) | 1997-11-20 | 2012-11-20 | Optonol Ltd. | Fluid drainage device, delivery device, and associated methods of use and manufacture |
US20030212383A1 (en) * | 2001-01-05 | 2003-11-13 | Dana Cote | System and methods for reducing intraocular pressure |
US9603741B2 (en) | 2000-05-19 | 2017-03-28 | Michael S. Berlin | Delivery system and method of use for the eye |
US6962573B1 (en) | 2000-10-18 | 2005-11-08 | Wilcox Michael J | C-shaped cross section tubular ophthalmic implant for reduction of intraocular pressure in glaucomatous eyes and method of use |
US7488303B1 (en) * | 2002-09-21 | 2009-02-10 | Glaukos Corporation | Ocular implant with anchor and multiple openings |
US7678065B2 (en) | 2001-05-02 | 2010-03-16 | Glaukos Corporation | Implant with intraocular pressure sensor for glaucoma treatment |
WO2002089699A2 (en) | 2001-05-03 | 2002-11-14 | Glaukos Corporation | Medical device and methods of use for glaucoma treatment |
US7186232B1 (en) | 2002-03-07 | 2007-03-06 | Glaukoa Corporation | Fluid infusion methods for glaucoma treatment |
US9301875B2 (en) | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
US7699882B2 (en) * | 2002-09-17 | 2010-04-20 | Iscience Interventional Corporation | Apparatus and method for surgical bypass of aqueous humor |
JP2007526013A (en) * | 2003-06-16 | 2007-09-13 | ソルクス インコーポレイテッド | Shunt device for treating glaucoma |
US20100173866A1 (en) * | 2004-04-29 | 2010-07-08 | Iscience Interventional Corporation | Apparatus and method for ocular treatment |
US8246569B1 (en) * | 2004-08-17 | 2012-08-21 | California Institute Of Technology | Implantable intraocular pressure drain |
US10219942B1 (en) * | 2005-12-03 | 2019-03-05 | S. Gregory Smith | Eye implant devices and method and device for implanting such devices for treatment of glaucoma |
WO2008005873A2 (en) * | 2006-06-30 | 2008-01-10 | Aquesys Inc. | Methods, systems and apparatus for relieving pressure in an organ |
US8974511B2 (en) | 2010-11-15 | 2015-03-10 | Aquesys, Inc. | Methods for treating closed angle glaucoma |
US10085884B2 (en) | 2006-06-30 | 2018-10-02 | Aquesys, Inc. | Intraocular devices |
US8663303B2 (en) | 2010-11-15 | 2014-03-04 | Aquesys, Inc. | Methods for deploying an intraocular shunt from a deployment device and into an eye |
US8308701B2 (en) | 2010-11-15 | 2012-11-13 | Aquesys, Inc. | Methods for deploying intraocular shunts |
US8801766B2 (en) | 2010-11-15 | 2014-08-12 | Aquesys, Inc. | Devices for deploying intraocular shunts |
US9095411B2 (en) | 2010-11-15 | 2015-08-04 | Aquesys, Inc. | Devices for deploying intraocular shunts |
EP2088976B1 (en) | 2006-11-10 | 2019-07-03 | Glaukos Corporation | Uveoscleral shunt |
US7740604B2 (en) | 2007-09-24 | 2010-06-22 | Ivantis, Inc. | Ocular implants for placement in schlemm's canal |
US20170360609A9 (en) | 2007-09-24 | 2017-12-21 | Ivantis, Inc. | Methods and devices for increasing aqueous humor outflow |
US8734377B2 (en) | 2007-09-24 | 2014-05-27 | Ivantis, Inc. | Ocular implants with asymmetric flexibility |
US20090082862A1 (en) | 2007-09-24 | 2009-03-26 | Schieber Andrew T | Ocular Implant Architectures |
US8512404B2 (en) | 2007-11-20 | 2013-08-20 | Ivantis, Inc. | Ocular implant delivery system and method |
US8808222B2 (en) | 2007-11-20 | 2014-08-19 | Ivantis, Inc. | Methods and apparatus for delivering ocular implants into the eye |
US8337509B2 (en) | 2007-11-20 | 2012-12-25 | Ivantis, Inc. | Methods and apparatus for delivering ocular implants into the eye |
US8109896B2 (en) * | 2008-02-11 | 2012-02-07 | Optonol Ltd. | Devices and methods for opening fluid passageways |
US8267882B2 (en) | 2008-03-05 | 2012-09-18 | Ivantis, Inc. | Methods and apparatus for treating glaucoma |
US20100056977A1 (en) * | 2008-08-26 | 2010-03-04 | Thaddeus Wandel | Trans-corneal shunt and method |
US8425473B2 (en) | 2009-01-23 | 2013-04-23 | Iscience Interventional Corporation | Subretinal access device |
US20100191177A1 (en) * | 2009-01-23 | 2010-07-29 | Iscience Interventional Corporation | Device for aspirating fluids |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
WO2012071476A2 (en) | 2010-11-24 | 2012-05-31 | David Haffner | Drug eluting ocular implant |
US9693899B2 (en) | 2009-07-09 | 2017-07-04 | Ivantis, Inc. | Single operator device for delivering an ocular implant |
CA2766192C (en) | 2009-07-09 | 2017-10-24 | Ivantis, Inc. | Ocular implants for residing partially in schlemm's canal |
CN102647960A (en) | 2009-10-23 | 2012-08-22 | 伊万提斯公司 | Ocular implant system and method |
US8277418B2 (en) | 2009-12-23 | 2012-10-02 | Alcon Research, Ltd. | Ophthalmic valved trocar cannula |
US8343106B2 (en) | 2009-12-23 | 2013-01-01 | Alcon Research, Ltd. | Ophthalmic valved trocar vent |
US9510973B2 (en) | 2010-06-23 | 2016-12-06 | Ivantis, Inc. | Ocular implants deployed in schlemm's canal of the eye |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
US8657776B2 (en) | 2011-06-14 | 2014-02-25 | Ivantis, Inc. | Ocular implants for delivery into the eye |
WO2013040079A1 (en) | 2011-09-13 | 2013-03-21 | Dose Medical Corporation | Intraocular physiological sensor |
US8765210B2 (en) | 2011-12-08 | 2014-07-01 | Aquesys, Inc. | Systems and methods for making gelatin shunts |
US8663150B2 (en) | 2011-12-19 | 2014-03-04 | Ivantis, Inc. | Delivering ocular implants into the eye |
US9358156B2 (en) | 2012-04-18 | 2016-06-07 | Invantis, Inc. | Ocular implants for delivery into an anterior chamber of the eye |
WO2014085450A1 (en) | 2012-11-28 | 2014-06-05 | Ivantis, Inc. | Apparatus for delivering ocular implants into an anterior chamber of the eye |
US9125723B2 (en) | 2013-02-19 | 2015-09-08 | Aquesys, Inc. | Adjustable glaucoma implant |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
EP3068354B1 (en) | 2013-11-14 | 2023-06-28 | Aquesys, Inc. | Intraocular shunt inserter |
WO2016011056A1 (en) | 2014-07-14 | 2016-01-21 | Ivantis, Inc. | Ocular implant delivery system and method |
US11197779B2 (en) | 2015-08-14 | 2021-12-14 | Ivantis, Inc. | Ocular implant with pressure sensor and delivery system |
WO2017106517A1 (en) | 2015-12-15 | 2017-06-22 | Ivantis, Inc. | Ocular implant and delivery system |
CA3022830A1 (en) | 2016-04-20 | 2017-10-26 | Harold Alexander Heitzmann | Bioresorbable ocular drug delivery device |
CA3025526A1 (en) | 2016-06-02 | 2017-12-07 | Aquesys, Inc. | Intraocular drug delivery |
US10952898B2 (en) | 2018-03-09 | 2021-03-23 | Aquesys, Inc. | Intraocular shunt inserter |
US11135089B2 (en) | 2018-03-09 | 2021-10-05 | Aquesys, Inc. | Intraocular shunt inserter |
CN109907857B (en) * | 2019-02-28 | 2023-10-31 | 中国人民解放军第四军医大学 | Device for injecting polyester fiber microspheres in front of eyeballs of mice |
EP4274529A1 (en) | 2021-01-11 | 2023-11-15 | Alcon Inc. | Systems and methods for viscoelastic delivery |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4037604A (en) * | 1976-01-05 | 1977-07-26 | Newkirk John B | Artifical biological drainage device |
US4554918A (en) * | 1982-07-28 | 1985-11-26 | White Thomas C | Ocular pressure relief device |
US4729761A (en) | 1985-11-27 | 1988-03-08 | White Thomas C | Tissue-implantable, fluid-dissipating device |
US4936825A (en) * | 1988-04-11 | 1990-06-26 | Ungerleider Bruce A | Method for reducing intraocular pressure caused by glaucoma |
US5071408A (en) * | 1988-10-07 | 1991-12-10 | Ahmed Abdul Mateen | Medical valve |
US5785674A (en) * | 1988-10-07 | 1998-07-28 | Mateen; Ahmed Abdul | Device and method for treating glaucoma |
US5073163A (en) * | 1990-01-29 | 1991-12-17 | Lippman Myron E | Apparatus for treating glaucoma |
US5041081A (en) * | 1990-05-18 | 1991-08-20 | Odrich Ronald B | Ocular implant for controlling glaucoma |
US5397300A (en) | 1990-05-31 | 1995-03-14 | Iovision, Inc. | Glaucoma implant |
US5178604A (en) * | 1990-05-31 | 1993-01-12 | Iovision, Inc. | Glaucoma implant |
US5454796A (en) | 1991-04-09 | 1995-10-03 | Hood Laboratories | Device and method for controlling intraocular fluid pressure |
US5370607A (en) | 1992-10-28 | 1994-12-06 | Annuit Coeptis, Inc. | Glaucoma implant device and method for implanting same |
US5743868A (en) | 1994-02-14 | 1998-04-28 | Brown; Reay H. | Corneal pressure-regulating implant device |
US5725493A (en) | 1994-12-12 | 1998-03-10 | Avery; Robert Logan | Intravitreal medicine delivery |
US5626558A (en) | 1995-05-05 | 1997-05-06 | Suson; John | Adjustable flow rate glaucoma shunt and method of using same |
US5968058A (en) | 1996-03-27 | 1999-10-19 | Optonol Ltd. | Device for and method of implanting an intraocular implant |
US5893837A (en) | 1997-02-28 | 1999-04-13 | Staar Surgical Company, Inc. | Glaucoma drain implanting device and method |
US5752928A (en) | 1997-07-14 | 1998-05-19 | Rdo Medical, Inc. | Glaucoma pressure regulator |
-
2000
- 2000-02-24 US US09/511,979 patent/US6471666B1/en not_active Expired - Lifetime
-
2002
- 2002-06-13 US US10/171,354 patent/US20020193725A1/en not_active Abandoned
Cited By (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9827143B2 (en) | 1999-04-26 | 2017-11-28 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US10492950B2 (en) | 1999-04-26 | 2019-12-03 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US10568762B2 (en) | 1999-04-26 | 2020-02-25 | Glaukos Corporation | Stent for treating ocular disorders |
US9492320B2 (en) | 1999-04-26 | 2016-11-15 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US9993368B2 (en) | 2000-04-14 | 2018-06-12 | Glaukos Corporation | System and method for treating an ocular disorder |
US10485702B2 (en) | 2000-04-14 | 2019-11-26 | Glaukos Corporation | System and method for treating an ocular disorder |
US9572963B2 (en) | 2001-04-07 | 2017-02-21 | Glaukos Corporation | Ocular disorder treatment methods and systems |
US10406029B2 (en) | 2001-04-07 | 2019-09-10 | Glaukos Corporation | Ocular system with anchoring implant and therapeutic agent |
US9987472B2 (en) | 2001-04-07 | 2018-06-05 | Glaukos Corporation | Ocular implant delivery systems |
US10828473B2 (en) | 2001-04-07 | 2020-11-10 | Glaukos Corporation | Ocular implant delivery system and methods thereof |
US10285856B2 (en) | 2001-08-28 | 2019-05-14 | Glaukos Corporation | Implant delivery system and methods thereof for treating ocular disorders |
US10485701B2 (en) | 2002-04-08 | 2019-11-26 | Glaukos Corporation | Devices and methods for glaucoma treatment |
US8945038B2 (en) | 2003-05-05 | 2015-02-03 | Transcend Medical, Inc. | Internal shunt and method for treating glaucoma |
US9844462B2 (en) | 2003-05-05 | 2017-12-19 | Novartis Ag | Internal shunt and method for treating glaucoma |
US8444588B2 (en) | 2003-05-05 | 2013-05-21 | Transcend Medical, Inc. | Internal shunt and method for treating glaucoma |
US7850638B2 (en) | 2003-11-14 | 2010-12-14 | Transcend Medical, Inc. | Ocular pressure regulation |
US8486000B2 (en) | 2003-11-14 | 2013-07-16 | Transcend Medical, Inc. | Ocular pressure regulation |
US8128588B2 (en) | 2003-11-14 | 2012-03-06 | Transcend Medical, Inc. | Ocular pressure regulation |
US9351873B2 (en) | 2003-11-14 | 2016-05-31 | Transcend Medical, Inc. | Ocular pressure regulation |
US10226380B2 (en) | 2003-11-14 | 2019-03-12 | Novartis Ag | Ocular pressure regulation |
US7815592B2 (en) | 2003-11-14 | 2010-10-19 | Transcend Medical, Inc. | Ocular pressure regulation |
US8728021B2 (en) | 2003-11-14 | 2014-05-20 | Transcend Medical, Inc. | Ocular pressure regulation |
US8808220B2 (en) | 2003-11-14 | 2014-08-19 | Transcend Medical, Inc. | Ocular pressure regulation |
US7291125B2 (en) | 2003-11-14 | 2007-11-06 | Transcend Medical, Inc. | Ocular pressure regulation |
US8758289B2 (en) | 2003-11-14 | 2014-06-24 | Transcend Medical, Inc. | Ocular pressure regulation |
US8771218B2 (en) | 2003-11-14 | 2014-07-08 | Transcend Medical, Inc. | Ocular pressure regulation |
US20090043321A1 (en) * | 2004-04-29 | 2009-02-12 | Iscience Interventional Corporation | Apparatus And Method For Surgical Enhancement Of Aqueous Humor Drainage |
US20050267398A1 (en) * | 2004-05-27 | 2005-12-01 | Dimitri Protopsaltis | Glaucoma shunt |
EP2526910A1 (en) | 2006-01-17 | 2012-11-28 | Transcend Medical, Inc. | Glaucoma treatment device |
EP3632385A1 (en) | 2006-01-17 | 2020-04-08 | Novartis AG | Glaucoma treatment device |
US8734378B2 (en) | 2006-01-17 | 2014-05-27 | Transcend Medical, Inc. | Glaucoma treatment device |
US8814819B2 (en) | 2006-01-17 | 2014-08-26 | Transcend Medical, Inc. | Glaucoma treatment device |
US8721656B2 (en) | 2006-01-17 | 2014-05-13 | Transcend Medical, Inc. | Glaucoma treatment device |
WO2007084582A2 (en) | 2006-01-17 | 2007-07-26 | Forsight Labs, Llc | Drug delivery treatment device |
US9084662B2 (en) | 2006-01-17 | 2015-07-21 | Transcend Medical, Inc. | Drug delivery treatment device |
US9668917B2 (en) | 2006-01-17 | 2017-06-06 | Novartis Ag | Drug delivery treatment device |
US11786402B2 (en) | 2006-01-17 | 2023-10-17 | Alcon Inc. | Glaucoma treatment device |
EP3338743A1 (en) | 2006-01-17 | 2018-06-27 | Novartis Ag | Drug delivery treatment device |
EP3005996A1 (en) | 2006-01-17 | 2016-04-13 | Transcend Medical, Inc. | Glaucoma treatment device |
US8801649B2 (en) | 2006-01-17 | 2014-08-12 | Transcend Medical, Inc. | Glaucoma treatment device |
US9398977B2 (en) | 2006-01-17 | 2016-07-26 | Transcend Medical, Inc. | Glaucoma treatment device |
US9789000B2 (en) | 2006-01-17 | 2017-10-17 | Novartis Ag | Glaucoma treatment device |
US9421130B2 (en) | 2006-01-17 | 2016-08-23 | Novartis Ag. | Glaucoma treatment device |
US10905590B2 (en) | 2006-01-17 | 2021-02-02 | Alcon Inc. | Glaucoma treatment device |
EP3838236A1 (en) | 2006-01-17 | 2021-06-23 | Alcon Inc. | Glaucoma treatment device |
US9585789B2 (en) | 2007-07-17 | 2017-03-07 | Novartis Ag | Ocular implant with hydrogel expansion capabilities |
US8672870B2 (en) | 2007-07-17 | 2014-03-18 | Transcend Medical, Inc. | Ocular implant with hydrogel expansion capabilities |
US20090177138A1 (en) * | 2007-11-07 | 2009-07-09 | Brown Reay H | Shunt Device for Glaucoma Treatment |
US10016301B2 (en) | 2008-06-25 | 2018-07-10 | Novartis Ag | Ocular implant with shape change capabilities |
US8617139B2 (en) | 2008-06-25 | 2013-12-31 | Transcend Medical, Inc. | Ocular implant with shape change capabilities |
US10531983B2 (en) | 2009-01-28 | 2020-01-14 | Novartis Ag | Ocular implant with stiffness qualities, methods of implantation and system |
US11839571B2 (en) | 2009-01-28 | 2023-12-12 | Alcon Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US11344448B2 (en) | 2009-01-28 | 2022-05-31 | Alcon Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8167939B2 (en) | 2009-01-28 | 2012-05-01 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US9763828B2 (en) | 2009-01-28 | 2017-09-19 | Novartis Ag | Ocular implant with stiffness qualities, methods of implantation and system |
US8262726B2 (en) | 2009-01-28 | 2012-09-11 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8574294B2 (en) | 2009-01-28 | 2013-11-05 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8377122B2 (en) | 2009-01-28 | 2013-02-19 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8172899B2 (en) | 2009-01-28 | 2012-05-08 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US20120281208A1 (en) * | 2009-07-21 | 2012-11-08 | National University Corp. Okayama University | Chamber for optical observation, method for optically observing sample, and method for manufacturing lower transparent plate |
US8529492B2 (en) | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
US9089392B2 (en) | 2009-12-23 | 2015-07-28 | Transcend Medical, Inc. | Drug delivery devices and methods |
US9549846B2 (en) | 2009-12-23 | 2017-01-24 | Novartis Ag | Drug delivery devices and methods |
US10842671B2 (en) | 2010-11-15 | 2020-11-24 | Aquesys, Inc. | Intraocular shunt placement in the suprachoroidal space |
US8758290B2 (en) | 2010-11-15 | 2014-06-24 | Aquesys, Inc. | Devices and methods for implanting a shunt in the suprachoroidal space |
US9980854B2 (en) | 2010-11-15 | 2018-05-29 | Aquesys, Inc. | Shunt placement through the sclera |
US10004638B2 (en) | 2010-11-15 | 2018-06-26 | Aquesys, Inc. | Intraocular shunt delivery |
US8852137B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for implanting a soft gel shunt in the suprachoroidal space |
US10307293B2 (en) | 2010-11-15 | 2019-06-04 | Aquesys, Inc. | Methods for intraocular shunt placement |
US10307292B2 (en) | 2011-07-18 | 2019-06-04 | Mor Research Applications Ltd | Device for adjusting the intraocular pressure |
US10080682B2 (en) | 2011-12-08 | 2018-09-25 | Aquesys, Inc. | Intrascleral shunt placement |
US9883969B2 (en) | 2011-12-08 | 2018-02-06 | Aquesys, Inc. | Intrascleral shunt placement |
US11197780B2 (en) | 2012-03-26 | 2021-12-14 | Glaukos Corporation | System and method for delivering multiple ocular implants |
US10271989B2 (en) | 2012-03-26 | 2019-04-30 | Glaukos Corporation | System and method for delivering multiple ocular implants |
US11944573B2 (en) | 2012-03-26 | 2024-04-02 | Glaukos Corporation | System and method for delivering multiple ocular implants |
WO2013155252A1 (en) * | 2012-04-11 | 2013-10-17 | Baylor College Of Medicine | Ophthalmic implant |
US10085633B2 (en) | 2012-04-19 | 2018-10-02 | Novartis Ag | Direct visualization system for glaucoma treatment |
US9414962B2 (en) | 2012-04-23 | 2016-08-16 | Das Agarwal Ghansham | Device for treatment of glaucoma and prevention of sub-scleral fibrosis and blockage |
US9241832B2 (en) | 2012-04-24 | 2016-01-26 | Transcend Medical, Inc. | Delivery system for ocular implant |
US10912676B2 (en) | 2012-04-24 | 2021-02-09 | Alcon Inc. | Delivery system for ocular implant |
US9155656B2 (en) | 2012-04-24 | 2015-10-13 | Transcend Medical, Inc. | Delivery system for ocular implant |
US9907697B2 (en) | 2012-04-24 | 2018-03-06 | Novartis Ag | Delivery system for ocular implant |
US20130317411A1 (en) * | 2012-05-23 | 2013-11-28 | Ghansham Das AGARWAL | Device for Treatment of Glaucoma |
US9480598B2 (en) | 2012-09-17 | 2016-11-01 | Novartis Ag | Expanding ocular implant devices and methods |
RU2524197C2 (en) * | 2012-10-24 | 2014-07-27 | Закрытое акционерное общество "Екатеринбургский центр МНТК "Микрохирургия глаза" | Method for surgical treatment of closed-angle glaucoma with organic block of angle of anterior chamber with preserving native crystalline lens |
US9763829B2 (en) | 2012-11-14 | 2017-09-19 | Novartis Ag | Flow promoting ocular implant |
US10195078B2 (en) | 2013-02-19 | 2019-02-05 | Aquesys, Inc. | Adjustable intraocular flow regulation |
US10195079B2 (en) | 2013-02-19 | 2019-02-05 | Aquesys, Inc. | Adjustable intraocular implant |
US10524959B2 (en) | 2013-02-27 | 2020-01-07 | Aquesys, Inc. | Intraocular shunt implantation methods and devices |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US11559430B2 (en) | 2013-03-15 | 2023-01-24 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US9987163B2 (en) | 2013-04-16 | 2018-06-05 | Novartis Ag | Device for dispensing intraocular substances |
US10369048B2 (en) | 2013-06-28 | 2019-08-06 | Aquesys, Inc. | Intraocular shunt implantation |
US10959941B2 (en) | 2014-05-29 | 2021-03-30 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
US11612517B2 (en) | 2015-06-03 | 2023-03-28 | Aquesys, Inc. | Ab externo intraocular shunt placement |
US10470927B2 (en) | 2015-06-03 | 2019-11-12 | Aquesys, Inc. | AB externo intraocular shunt placement |
US10463537B2 (en) | 2015-06-03 | 2019-11-05 | Aquesys Inc. | Ab externo intraocular shunt placement |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11058581B2 (en) | 2017-07-20 | 2021-07-13 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
US11166848B2 (en) | 2017-07-20 | 2021-11-09 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
US11166849B2 (en) | 2017-07-20 | 2021-11-09 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and methods for making and using same |
US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
US11246753B2 (en) | 2017-11-08 | 2022-02-15 | Aquesys, Inc. | Manually adjustable intraocular flow regulation |
US11517477B2 (en) | 2019-10-10 | 2022-12-06 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
US11529258B2 (en) | 2020-01-23 | 2022-12-20 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts and associated systems and methods |
US11291585B2 (en) | 2020-02-14 | 2022-04-05 | Shifamed Holdings, Llc | Shunting systems with rotation-based flow control assemblies, and associated systems and methods |
US11737920B2 (en) | 2020-02-18 | 2023-08-29 | Shifamed Holdings, Llc | Adjustable flow glaucoma shunts having non-linearly arranged flow control elements, and associated systems and methods |
US11766355B2 (en) | 2020-03-19 | 2023-09-26 | Shifamed Holdings, Llc | Intraocular shunts with low-profile actuation elements and associated systems and methods |
US11596550B2 (en) | 2020-04-16 | 2023-03-07 | Shifamed Holdings, Llc | Adjustable glaucoma treatment devices and associated systems and methods |
WO2022149249A1 (en) * | 2021-01-07 | 2022-07-14 | 株式会社ドックスネット | Implant and implant system |
US11865283B2 (en) | 2021-01-22 | 2024-01-09 | Shifamed Holdings, Llc | Adjustable shunting systems with plate assemblies, and associated systems and methods |
Also Published As
Publication number | Publication date |
---|---|
US6471666B1 (en) | 2002-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6471666B1 (en) | Injectable glaucoma device | |
US10492948B2 (en) | Glaucoma drainage shunts and methods of use | |
JP3088746B2 (en) | Glaucoma implant | |
JP3240474B2 (en) | Glaucoma implants with temporary flow restriction seals | |
US5713844A (en) | Device and method for regulating intraocular pressure | |
US5433701A (en) | Apparatus for reducing ocular pressure | |
US4604087A (en) | Aqueous humor drainage device | |
US6589203B1 (en) | Glaucoma drainage device implant | |
US4331130A (en) | Securing device to the cornea to prevent anterior chamber prolapse | |
KR100187526B1 (en) | Pressure-relieving device and process for implanting | |
US6050970A (en) | Method and apparatus for inserting a glaucoma implant in an anterior and posterior segment of the eye | |
US7776002B2 (en) | Ophthalmic implant for treating glaucoma | |
US4340037A (en) | Method to prevent collapse of the anterior chamber utilizing a terminal with eye engaging detents | |
US20080306429A1 (en) | Uveoscleral drainage device | |
JP2002521145A (en) | Sutureless implantable devices and methods for treating glaucoma | |
MXPA05000807A (en) | Uveoscleral drainage device. | |
JPH0417055B2 (en) | ||
Smith et al. | Results of another modality for extending glaucoma drainage tubes | |
JP2023501629A (en) | An implant device for ocular diseases that can reduce intraocular pressure in an easy and safe way | |
CA1238833A (en) | Aqueous humor drainage device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |